CRD-1367799

N/A

Report date: 2024/12/20 15:58:09

NME

Base Information

Drug NameCRD-1367799

Drug Alias NameCRD-1367799

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitorsEukaryotic translation initiation factor 2-alpha kinase 4 inhibitors

TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3Eukaryotic translation initiation factor 2-alpha kinase 4

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNagoya City University

China Registration ClassN/A

Develop Information

Active CompaniesNagoya City University

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A